White paper
From deal strategy to financial reality: Connecting pre-deal analysis and post-deal monitoring for pharma manufacturers
Improve pricing, contracting, and GTN decisions with a connected commercial planning approach.
Read the white paper
White paper
From deal strategy to financial reality: Connecting pre-deal analysis and post-deal monitoring for pharma manufacturers
Improve pricing, contracting, and GTN decisions with a connected commercial planning approach.
Download the white paper to learn how Anaplan helps pharma manufacturers:
- Connect pre-deal analysis, GTN forecasting, and post-deal monitoring
- Model pricing and contracting scenarios using shared financial assumptions
- Compare actual performance against pre-deal expectations to identify revenue leakage
- Improve forecast accuracy by connecting deal assumptions to GTN planning
Pricing and contracting decisions are becoming more complex as pricing reform, payer demands, and market dynamics continue to evolve.
This white paper explores how connecting every stage of the deal lifecycle — from pre-deal analysis through GTN forecasting and post-deal monitoring — helps organizations improve forecast reliability, reduce accrual errors, and make more informed commercial decisions.
